There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

Eli Lilly And Co. (NYSE:LLY) is ramping up its legal campaign against the compounding companies temporarily allowed to make ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...